Successful liver transplantation from a donor with occlusive portal vein thrombosis

Introduction. The shortage of donor organs has been and remains the basic problem of clinical transplantation and the expansion of the organ pool by using marginal donor organs has become one of its solutions. In this regard, every decision to use a "non-standard" or "non ideal" organ for transplantation should be made carefully.
Aim. Demonstration of successful liver transplantation from a donor with brain death and occlusive thrombosis of the splanchnic venous system.
Description. A 34-year-old donor without serious concomitant pathology was diagnosed with total portal thrombosis during liver procurement. After cold aortic perfusion, a thrombectomy from the portal vein was performed. At the “backtable” stage, an additional perfusion was made through the portal vein, the results of which confirmed the patency of the portal system. The liver graft was transplanted to a 33-year-old recipient; the postoperative period was uneventful, the patient was discharged on the 17-th postoperative day.
Conclusions. Portal vein thrombosis in a donor liver is rare. A positive decision on liver transplantation from a donor with portal vein thrombosis should be based on the confirmed patency of the portal system. It is desirable that these data be supplemented by a histological examination of the donor liver. The donor organs shortage needs to expand the criteria for post-mortem organ donation. However, every decision should be made in the light of individual characteristics of the donor-recipient pair.

1. Badawy A, Kaido T, Uemoto S. Current status of liver transplantation using marginal grafts. J Invest Surg. 2020;33(6):553–564. PMID: 30457408 https://doi.org/10.1080/08941939.2018.1517197

2. Lozanovski VJ, Khajeh E, Fonouni H, Pfeiffenberger J, von Haken R, Brenner T, et al. Correction to: the impact of major extended donor criteria on graft failure and patient mortality after liver transplantation. Langenbecks Arch Surg. 2018;403(6):719–731. PMID: 30112639 https://doi.org/10.1007/s00423-018-1704-z

3. Muhammad H, Zaffar D, Tehreem A, Ting PS, Simsek C, Turan I, et al. An update on usage of high-risk donors in liver transplantation. J Clin Med. 2021;11(1):215. PMID: 35011956 https:// doi.org/10.3390/jcm11010215

4. Kwong AJ, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, et al. OPTN/SRTR 2019 annual data report: liver. Am J Transplant. 2021;21(Suppl 2):208–315. PMID: 33595192 https://doi.org/10.1111/ajt.16494

5. Kim JM, Kim DG, Kim J, Lee K, Lee KW, Ryu JH, et al. Outcomes after liver transplantation in Korea: incidence and risk factors from Korean transplantation registry. Clin Mol Hepatol. 2021;27(3):451–462. PMID: 33525077 https://doi.org/10.3350/cmh.2020.0292

6. Vinogradov VL, Khubutiya MS, Gubarev KK, Dulub VG, Zakhlevnyy AI, Svetlakova DS, et al. Characteristics of postmortem organ donors in N.V. Sklifosovsky Research Institute for Emergency Medicine and the donor hospitals of FMBA of Russia (2008–2017). Transplantologiya. The Russian Journal of Transplantation. 2018;10(3):185–196. (In Russ.). https:// doi.org/10.23873/2074-0506-2018-10-3-185-196

7. Lozanovski VJ, Kerr LTB, Khajeh E, Ghamarnejad O, Pfeiffenberger J, Hoffmann K, et al. Liver grafts with major extended donor criteria may expand the organ pool for patients with hepatocellular carcinoma. J Clin Med. 2019;15;8(10):1692. PMID: 31618968 https://doi.org/10.3390/jcm8101692

8. Yanaga K, Stieber A, Koneru B, Mieles LA, Tzakis AG, Starzl TE. Portal vein thromboembolism of liver allografts from splenectomized donors. Transplantation. 1989;47(2):399–400. PMID: 2645726 https://doi.org/10.1097/00007890-198902000-00046

9. Adair A, Brooke-Smith ME, Akyol M, Powell JJ. Maximizing use of marginal liver grafts for transplantation: a case report of absent donor extrahepatic portal vein. Transplantation. 2011;91(6):e42–43. PMID: 21383602 https://doi.org/10.1097/TP.0b013e3182090f8c

10. Dondossola D, Lonati C, Kersik A, Zanella A, Gatti S, Rossi G. Graft portal vein thrombosis before liver transplant. Transplantation. 2020;104(1):e44–e45. PMID: 31449186 https://doi.org/10.1097/TP.0000000000002919

11. Kheyrandish S, Rastgar A, Arab-Zozani M, Sarab GA. Portal vein thrombosis might develop by COVID-19 infection or vaccination: a systematic review of case-report studies. Front Med (Lausanne). 2021;8:794599. PMID: 34970570 https://doi.org/10.3389/fmed.2021.794599

12. Bogovic N, Doenecke A, Hart C, Lürken L, Heimerl S, Eissnert C, et al. Covid19 vaccination-associated portal vein thrombosis – an interdisciplinary clinical challenge. Clin Res Hepatol Gastroenterol. 2022;46(8):101932. PMID: 35504460 https://doi.org/10.1016/j.clinre.2022.101932